Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonexai Kidoikhammouan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Oncology Research|December 22, 2025
Molecular Mechanisms of Gemcitabine Resistance in CholangiocarcinomaSonexai Kidoikhammouan, Charupong Saengboonmee, Sopit Wongkham, et al.
In Vivo (Athens, Greece)|August 26, 2024
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma <i>In Vitro</i> and <i>In Vivo</i>Prin Sungwan, Sonexai Kidoikhammouan, Unchalee Thonsri, et al.
Journal of Cancer Research and Therapeutics|March 19, 2019
Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinomaSonexai Kidoikhammouan, Wunchana Seubwai, Atit Silsirivanit, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 14, 2013
TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitroSonexai Kidoikhammouan, Wunchana Seubwai, Nattawat Tantapotinan, et al.
Plos One|July 10, 2020
Correction: Patch testing in Lao medical studentsCatriona I Wootton, Mick Soukavong, Sonexai Kidoikhammouan, et al.
Plos One|January 17, 2020
Patch testing in Lao medical studentsCatriona I Wootton, Mick Soukavong, Sonexai Kidoikhammouan, et al.
Anticancer Research|December 3, 2024
Targeting EGFR Activation to Overcome Gemcitabine Resistance in CholangiocarcinomaSonexai Kidoikhammouan, Worachart Lert-Itthiporn, Raksawan Deenonpoe, et al.
Biomedical Reports|March 20, 2026
Integrated transcriptomic and molecular docking analysis identifies Rhotekin 2 as a promising therapeutic target for overcoming gemcitabine resistance in cholangiocarcinomaSonexai Kidoikhammouan, Panupong Mahalapbutr, Prasertsri Ma-In, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|September 4, 2025
Bioinformatics analysis identified TCP1 and NOTCH1 as potential target molecules to overcome 5-fluorouracil resistance in cholangiocarcinomaSonexai Kidoikhammouan, Nopkamol Kanchanangkul, Worachart Lert-Itthiporn, et al.
Biochimica Et Biophysica Acta. General Subjects|October 9, 2023
Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insightMarutpong Detarya, Panupong Mahalapbutr, Orawan Waenphimai, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncology Research|December 22, 2025
Molecular Mechanisms of Gemcitabine Resistance in CholangiocarcinomaSonexai Kidoikhammouan, Charupong Saengboonmee, Sopit Wongkham, et al.
In Vivo (Athens, Greece)|August 26, 2024
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma <i>In Vitro</i> and <i>In Vivo</i>Prin Sungwan, Sonexai Kidoikhammouan, Unchalee Thonsri, et al.
Journal of Cancer Research and Therapeutics|March 19, 2019
Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinomaSonexai Kidoikhammouan, Wunchana Seubwai, Atit Silsirivanit, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 14, 2013
TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitroSonexai Kidoikhammouan, Wunchana Seubwai, Nattawat Tantapotinan, et al.
Plos One|July 10, 2020
Correction: Patch testing in Lao medical studentsCatriona I Wootton, Mick Soukavong, Sonexai Kidoikhammouan, et al.
Plos One|January 17, 2020
Patch testing in Lao medical studentsCatriona I Wootton, Mick Soukavong, Sonexai Kidoikhammouan, et al.
Anticancer Research|December 3, 2024
Targeting EGFR Activation to Overcome Gemcitabine Resistance in CholangiocarcinomaSonexai Kidoikhammouan, Worachart Lert-Itthiporn, Raksawan Deenonpoe, et al.
Biomedical Reports|March 20, 2026
Integrated transcriptomic and molecular docking analysis identifies Rhotekin 2 as a promising therapeutic target for overcoming gemcitabine resistance in cholangiocarcinomaSonexai Kidoikhammouan, Panupong Mahalapbutr, Prasertsri Ma-In, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|September 4, 2025
Bioinformatics analysis identified TCP1 and NOTCH1 as potential target molecules to overcome 5-fluorouracil resistance in cholangiocarcinomaSonexai Kidoikhammouan, Nopkamol Kanchanangkul, Worachart Lert-Itthiporn, et al.
Biochimica Et Biophysica Acta. General Subjects|October 9, 2023
Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insightMarutpong Detarya, Panupong Mahalapbutr, Orawan Waenphimai, et al.
Pageof 1